28 reports

By the year 2040, ## adult in ## will have diabetes.

  • Insulin Delivery
  • Type 1 Diabetes
  • World
  • Market Size
  • Animas Corporation

The company manufactures various therapeutic solutions and healthcare products.

  • Type 1 Diabetes
  • World
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

Drug analysis: Farxiga

9091 10000 7727

Drug analysis: Farxiga PRODUCT PROFILES Farxiga : Diabetes type ## Farxiga : Diabetes type ## LIST OF FIGURES Figure ##: Farxiga for type ## diabetes – SWOT analysis Figure ##: Datamonitor Healthcare drug assessment of Farxiga Figure ##: Datamonitor Healthcare drug assessment s

  • Diabetes
  • Sodium-Glucose Co-Transporter 2 Inhibitor
  • Type 1 Diabetes
  • European Union
  • United States

IT ACHIEVED BLOCKBUSTER STATUS IN 2011 AND IT HOLDS THE GLOBAL MARKET SHARE LEADERSHIP WITH A ##% VALUE MARKET SHARE IN THE GLP-## SEGMENT COMPARED WITH ##% IN 2012.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Sanofi S.A.

List of data sources List of Tables ##.

  • Insulin
  • Therapy
  • Type 1 Diabetes
  • United States
  • Forecast

Prevalence of Type ## Diabetes Mellitus, males (##s) Table ##.

  • Chronic Disease
  • Diabetes
  • Pathology
  • Type 1 Diabetes

INTERNATIONAL PROFILES OF HEALTH CARE SYSTEMS, 2013.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

INTERNATIONAL PROFILES OF HEALTH CARE SYSTEMS, 2013.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

INTERNATIONAL PROFILES OF HEALTH CARE SYSTEMS, 2013.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

International Profiles of Health Care Systems, 2013.

  • Type 1 Diabetes
  • Canada
  • North America
  • Eli Lilly & Co.
  • Novo Nordisk Group

INTERNATIONAL PROFILES OF HEALTH CARE SYSTEMS, 2013.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

GlobalData ViaCyte Inc' s, deal volume increased from one pharmaceuticals & healthcare deal in 2016 to two pharmaceuticals & healthcare deals in 2017.

  • Cell Therapy
  • Type 1 Diabetes
  • United States
  • Company Operations
  • ViaCyte, Inc.

GlobalData Lexicon Pharmaceuticals Inc' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Pharmaceutical
  • Therapy
  • Type 1 Diabetes
  • United States
  • Lexicon Pharmaceuticals, Inc.

GlobalData Adocia SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 Deal Type Equity Offerings Licensing Agreement No. of Deals ## ## Deal Value (US$ million) ##. ## NA Adocia SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 ADOCIA

  • Healthcare
  • Type 1 Diabetes
  • France
  • Company
  • Adocia

The company is one of the leaders in the healthcare industry, with its balanced portfolio offerings.

  • Immunochemistry Test
  • Type 1 Diabetes
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.

Previous studies in similar patients have assessed one or only a handful of these mediators.

  • Diabetes
  • Healthcare
  • Pharmaceutical
  • Type 1 Diabetes
  • United States

AMGEN INC GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products.

  • Therapy
  • Type 1 Diabetes
  • United States
  • World
  • Product Initiative

" This agreement reinforces our shift towards value-based healthcare.

  • Clinical Trial
  • Insulin Delivery
  • Type 1 Diabetes
  • United States
  • GlobalData's company

A total of ## participants from the age of four have been enrolled in the trial, which will last for DiAPREV-IT ##- DIAMYD five years.

  • Biotechnology
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Company
  • Product Initiative

GlobalData offers comprehensive geographic coverage across world' s most important sectors, focusing particularly on energy and healthcare.

  • Monoclonal Antibody
  • Type 1 Diabetes
  • United States
  • Company
  • GlobalData's company

TRAMP mice received intraperitoneal injection of ICT or vehicle.

  • Therapy
  • Type 1 Diabetes
  • World
  • Product Initiative
  • Shenogen Pharma Group

The prominent features of this report are - ##.

  • Clinical Trial
  • Endocrine Disease
  • Type 1 Diabetes
  • World
  • Product Initiative

International Business Machines Corp (IBM) is a provider of information technology (IT) products and services.

  • Diabetes
  • Medical Device
  • Medical Equipment
  • Type 1 Diabetes
  • United States

PIPELINE BY AMGEN INC., H## 2016 GLAXOSMITHKLINE PLC GlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products.

  • Glycoprotein
  • Type 1 Diabetes
  • World
  • Product Initiative
  • Xencor, Inc.

IT ACTS THROUGH GLP-## RECEPTORS.

  • Chronic Disease
  • Type 1 Diabetes
  • United States
  • World
  • Company

Regulations- Government, Healthcare and other environmental Varying government/ healthcare/ other environmental regulations in the US and overseas markets can influence the company' s business growth. ## Latest Company Outlook Statement The following statement has been t

  • Clinical Trial
  • Endocrine Disease
  • Pharmaceutical
  • Therapy
  • Type 1 Diabetes

" Increasing numbers of obese patients are turning to gastric bypass surgery as an effective means to rapidly and sustainably reduce weight and as a critical healthcare intervention, " said David Cory, President and CEO of Eiger.

  • Clinical Trial
  • Drug Discovery And Development
  • Type 1 Diabetes
  • World
  • Product Initiative

Clinicians could then make a more informed choice as to the most appropriate therapeutic option, while allowing healthcare providers to better allocate scarce healthcare resources. "

  • Cancer
  • DNA
  • Pathology
  • Type 1 Diabetes
  • Chronix Biomedical, Inc.